한글목차

세계의 엔도톡신 검사 시장은 규제 기준 강화, 기술 진보, 그리고 제약, 생명공학, 의료기기 산업에서의 제품안전성에 중점을 두고 현저한 성장을 이루고 있습니다. 2026년에 15억 달러로 예상되는 시장의 규모는 2033년까지 29억 달러에 이를 것으로 예측되며 예측 기간 동안 10%라는 견조한 CAGR을 기록할 전망입니다.

시장 개요

엔도톡신(지질다당류)은 그람 음성 박테리아의 외막에 존재하는 유해 물질입니다. 주사제, 생물학적 제제 또는 의료기기에 오염되면 발열, 패혈증 쇼크, 염증 반응 등 심각한 건강 피해를 일으킬 수 있습니다. 따라서 미국 식품의약국(FDA), 유럽의약청(EMA), 각종 의료당국 등 세계 규제기관은 모든 주사제 및 생물학적 제제에 대해 엄격한 엔도톡신 검사를 의무화하고 있습니다.

시장에서는 기존의 검사 방법을 넘어 자동화, 고처리량, 고감도 엔도톡신 검출 기술을 이용한 대폭적인 혁신이 발생하고 있습니다. 이 진화는 보다 높은 정확도, 신속한 결과, 그리고 엄격한 안전 기준과의 적합성을 확보하고, 제조업자나 연구 기관에 엔도톡신 오염을 검출 및 관리하기 위한 신뢰성 높은 솔루션을 제공합니다.

주요 촉진요인

엔도톡신 검사 시장의 확대를 촉진하는 요인은 다음과 같습니다.

• 1. 규제 요건 : 세계 각국의 규제 당국은 모든 생물학적 제제, 주사제, 의료기기에 대해 철저한 엔도톡신 검사를 의무화하고 있으며, 이는 시험 솔루션에 대한 안정적인 수요를 창출하고 있습니다.
• 2. 제약 및 생명공학 분야의 성장 : 백신, 생물학적 제제, 세포 및 유전자 치료의 개발 증가에 따라 환자의 안전성을 확보하기 위한 정밀한 엔도톡신 검출이 필수적입니다.
• 3. 기술적 진보 : 발색법, 비탁법, 겔 응고법 등의 자동화 및 고처리량 방법의 도입에 의해 검사의 효율성과 신뢰성이 향상하고 있습니다.
• 4. 환자 안전에 대한 주력 : 엔도톡신 관련 위험에 대한 인식이 증가함에 따라 기업은 엄격한 시험 프로토콜과 예방 조치의 도입을 추진하고 있습니다.
• 5. 신흥 시장 확대 : 아시아태평양 및 라틴아메리카에서의 의약품 및 의료기기 제조의 급속한 진전은 시장 진출기업에게 큰 성장 기회를 제공합니다.

비즈니스 기회

엔도톡신 검사 시장은 기업과 검사 기관에 여러 기회를 제공합니다.

• 자동화 및 고처리량 검사 : 자동화 시스템은 인위적 실수를 줄이고 재현성을 향상시켜 검사 사이클을 가속화합니다.
• 외부 위탁 및 맞춤 서비스 : 전문적인 엔도톡신 검사 서비스 제공업체는 특히 중소규모 제조업체에 비용 효율적인 솔루션을 제공합니다.
• 신흥 시장 진출 : 아시아태평양 및 라틴아메리카의 의료 인프라 및 의약품 생산 확대는 새로운 성장 경로를 열어줍니다.
• 혁신적인 제품 : 첨단 생물학적 제제 및 치료용 단백질을 위한 엔도톡신 마스킹(LER) 제품 및 엔도톡신 제거 솔루션의 개발은 중요한 성장 분야입니다.

지역별 분석

• 북미 : 주요 제약 회사 및 생명 공학 회사의 존재, 엄격한 규제 및 첨단 실험실 인프라로 북미가 시장을 독점하고 있습니다.
• 유럽 : 유럽에서는 강력한 규제 감독, 확립된 연구 기관, 자동화 엔도톡신 검사 기술의 보급 확대로 꾸준한 성장이 예상됩니다.
• 아시아태평양 : 급속한 산업화, 의약품 제조 확대, 의료 투자 증가 등을 바탕으로 아시아태평양은 가장 높은 CAGR로 성장할 것으로 예측됩니다.
• 라틴아메리카 : 의약품 생산 증가와 국제 품질 기준 채택은 시장 성장을 뒷받침합니다.
• 중동 및 아프리카 : 의료 인프라의 점진적인 개선과 환자 안전에 대한 의식 증가가 시장 발전에 기여하고 있습니다.

주요 기업

세계의 엔도톡신 검사 시장은 다수의 다국적 기업과 전문 연구소가 다양한 제품 및 서비스를 제공하고 있어 경쟁이 매우 치열한 상황입니다. 주요 시장 진출기업은 다음과 같습니다.

• Thermo Fisher Scientific
• Merck KGaA(MilliporeSigma)
• Charles River Laboratories
• Lonza Group
• bioMerieux SA
• Toxin Technology, Inc.
• Hycult Biotech
• Associates of Cape Cod, Inc.
• Sciex(Danaher)
• FUJIFILM Wako Chemicals USA Corporation
• IDEXX Laboratories, Inc.
• BioStress LLC
• R&D Systems(Bio Techne Corporation)
• CTS(Creative Bioarray/China)
• Insight Genomics, Inc.

이러한 기업들은 시장에서의 존재감을 강화하기 위해 지속적인 제품 혁신, 전략적 제휴, 합병, 지역 확대에 주력하고 있습니다.

시장 세분화

검사 방법별

• 겔 응고 엔도톡신 검사
• 발색법 엔도톡신 검사
• 비탁법 엔도톡신 검사

유형별

• 엔도톡신 검출 제품
• LAL 시험 시약
• 마이코플라스마 검출 및 제거
• PCR 마이코플라스마 검출 키트
• 마이코플라스마 제거 칵테일
• 맞춤 마이코플라즈마 검출 및 제거 서비스
• 부속품
• 측정기
• 엔도톡신 제거 제품
• 엔도톡신 마스킹(LER) 제품
• 지질다당류

용도별

• 의료기기 제조
• 의약품 제조
• 포장 제조
• 원재료 생산

지역별

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
  • 촉진요인
  • 억제요인
  • 시장 기회
• 밸류체인 분석
• COVID-19의 영향 분석
• Porter's Five Forces 분석
• 러시아-우크라이나 분쟁의 영향
• PESTLE 분석
• 규제 분석
• 가격 동향 분석
  • 현재 가격 및 미래 예측(2025-2033년)
  • 가격 영향요인

제3장 세계의 엔도톡신 검사 시장 전망(2020-2033년)

• 세계의 엔도톡신 검사 시장 전망 : 검사 방법별, 금액(10억 달러)(2020-2033년)
  • 겔 응고 엔도톡신 검사
  • 발색법 엔도톡신 검사
  • 비탁법 엔도톡신 검사
• 세계의 엔도톡신 검사 시장 전망 : 유형별, 금액(10억 달러)(2020-2033년)
  • 엔도톡신 검출 제품
  • LAL 테스트 시약
  • 마이코플라스마 검출 및 제거
  • PCR 마이코플라스마 검출 키트
  • 마이코플라스마 제거 칵테일
  • 맞춤 마이코플라스마 검출 및 제거 서비스
  • 부속품
  • 측정기
  • 엔도톡신 제거 제품
  • 엔도톡신 마스킹(LER) 제품
• 세계의 엔도톡신 검사 시장 전망 : 용도별, 금액(10억 달러)(2020-2033년)
  • 의료기기 제조
  • 의약품 제조
  • 포장 제조
  • 원재료 생산
• 세계의 엔도톡신 검사 시장 전망 : 지역별, 금액(10억 달러)(2020-2033년)
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제4장 북미의 엔도톡신 검사 시장 전망(2020-2033년)

제5장 유럽의 엔도톡신 검사 시장 전망(2020-2033년)

제6장 아시아태평양의 엔도톡신 검사 시장 전망(2020-2033년)

제7장 라틴아메리카의 엔도톡신 검사 시장 전망(2020-2033년)

제8장 중동 및 아프리카의 엔도톡신 검사 시장 전망(2020-2033년)

제9장 경쟁 구도

• 기업 대 부문 히트맵
• 기업의 시장 점유율 분석(2025년)
• 경쟁 대시보드
• 기업 프로파일
  • Thermo Fisher Scientific
  • Merck KGaA(MilliporeSigma)
  • Charles River Laboratories
  • Lonza Group
  • bioMerieux SA
  • Toxin Technology, Inc.
  • Hycult Biotech
  • Associates of Cape Cod, Inc.
  • Sciex(Danaher)
  • FUJIFILM Wako Chemicals USA Corporation

제10장 부록

영문목차

The global endotoxin testing market is experiencing remarkable growth, driven by rising regulatory standards, technological advancements, and increased emphasis on product safety across pharmaceutical, biotechnology, and medical device industries. The market, valued at USD 1.5 billion in 2026, is projected to reach USD 2.9 billion by 2033, registering a robust CAGR of 10% during the forecast period.

Market Overview

Endotoxins, or lipopolysaccharides, are toxic substances present in the outer membrane of Gram-negative bacteria. Their contamination in injectable drugs, biologics, and medical devices can lead to severe health complications, including fever, septic shock, and inflammatory responses. This has prompted regulatory agencies worldwide, such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and various pharmacopeial authorities, to mandate rigorous endotoxin testing for all injectable and biologic products.

The market has witnessed significant innovation, moving beyond traditional testing methods to incorporate automated, high-throughput, and highly sensitive endotoxin detection technologies. This evolution ensures higher accuracy, faster results, and compliance with stringent safety standards, providing manufacturers and research organizations with reliable solutions to detect and control endotoxin contamination.

Key Market Drivers

Several factors are fueling the expansion of the endotoxin testing market:

• 1. Regulatory Mandates: Global regulatory authorities require thorough endotoxin testing for all biologics, injectables, and medical devices, creating steady demand for testing solutions.
• 2. Pharmaceutical and Biotech Growth: The increasing development of vaccines, biologics, and cell and gene therapies necessitates precise endotoxin detection to ensure patient safety.
• 3. Technological Advancements: Adoption of automated, high-throughput methods such as chromogenic, turbidimetric, and gel clot assays enhances testing efficiency and reliability.
• 4. Focus on Patient Safety: Growing awareness of endotoxin-related risks drives companies to adopt stringent testing protocols and preventive measures.
• 5. Emerging Market Expansion: Rapid pharmaceutical and medical device manufacturing in Asia-Pacific and Latin America provides significant growth opportunities for market participants.

Business Opportunities

The endotoxin testing market offers multiple opportunities for companies and laboratories:

• Automation and High-Throughput Testing: Automated systems reduce human error, improve reproducibility, and accelerate testing cycles.
• Outsourced and Custom Services: Specialized endotoxin testing service providers offer cost-effective solutions, particularly for small and medium-sized manufacturers.
• Emerging Market Penetration: Increasing healthcare infrastructure and pharmaceutical production in Asia-Pacific and Latin America open new avenues for growth.
• Innovative Products: Development of low endotoxin recovery (LER) products and endotoxin removal solutions for advanced biologics and therapeutic proteins represents a significant growth segment.

Regional Analysis

• North America: North America dominates the market due to the presence of leading pharmaceutical and biotechnology companies, stringent regulations, and advanced laboratory infrastructure.
• Europe: Steady growth in Europe is driven by strong regulatory oversight, established research institutions, and growing adoption of automated endotoxin testing technologies.
• Asia Pacific: The Asia-Pacific region is expected to grow at the highest CAGR, fueled by rapid industrialization, expansion of pharmaceutical manufacturing, and increasing healthcare investments.
• Latin America: Market growth is supported by rising pharmaceutical production and adoption of international quality standards.
• Middle East & Africa: Gradual improvements in healthcare infrastructure and growing awareness of patient safety contribute to market development.

Key Players

The global endotoxin testing market is highly competitive, with numerous multinational corporations and specialized laboratories offering a wide range of products and services. Leading market participants include:

• Thermo Fisher Scientific
• Merck KGaA (MilliporeSigma)
• Charles River Laboratories
• Lonza Group
• bioMerieux SA
• Toxin Technology, Inc.
• Hycult Biotech
• Associates of Cape Cod, Inc.
• Sciex (Danaher)
• FUJIFILM Wako Chemicals USA Corporation
• IDEXX Laboratories, Inc.
• BioStress LLC
• R&D Systems (Bio Techne Corporation)
• CTS (Creative Bioarray / China)
• Insight Genomics, Inc.

These companies focus on continuous product innovation, strategic partnerships, mergers, and regional expansions to strengthen their market presence.

Market Segmentation

By Testing Methods:

• Gel Clot Endotoxin Test
• Chromogenic Endotoxin Test
• Turbidimetric Endotoxin Test

By Type:

• Endotoxin Detection Products
• LAL Test Reagents
• Mycoplasma Detection & Removal
• PCR Mycoplasma Detection Kit
• Mycoplasma Elimination Cocktail
• Mycoplasma Detection and Elimination Custom Services
• Accessories
• Instrumentation
• Endotoxin Removal Products
• Low Endotoxin Recovery (LER) Products
• Lipopolysaccharides

By Application:

• Medical Device Manufacturing
• Pharmaceutical Manufacturing
• Packaging Manufacture
• Raw Materials Production

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Endotoxin Testing Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2026
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. COVID-19 Impact Analysis
• 2.5. Porter's Fiver Forces Analysis
• 2.6. Impact of Russia-Ukraine Conflict
• 2.7. PESTLE Analysis
• 2.8. Regulatory Analysis
• 2.9. Price Trend Analysis
  • 2.9.1. Current Prices and Future Projections, 2025-2033
  • 2.9.2. Price Impact Factors

3. Global Endotoxin Testing Market Outlook, 2020 - 2033

• 3.1. Global Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
  • 3.1.1. Gel Clot Endotoxin Test
  • 3.1.2. Chromogenic Endotoxin Test
  • 3.1.3. Turbidimetric Endotoxin Test
• 3.2. Global Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
  • 3.2.1. Endotoxin Detection Products
  • 3.2.2. LAL Test Reagents
  • 3.2.3. Mycoplasma Detection & Removal
  • 3.2.4. PCR Mycoplasma Detection Kit
  • 3.2.5. Mycoplasma Elimination Cocktail
  • 3.2.6. Mycoplasma Detection and Elimination Custom Services
  • 3.2.7. Accessories
  • 3.2.8. Instrumentation
  • 3.2.9. Endotoxin Removal Products
  • 3.2.10. Low Endotoxin Recovery (LER) Products
• 3.3. Global Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
  • 3.3.1. Medical device manufacturing
  • 3.3.2. Pharmaceutical manufacturing
  • 3.3.3. Packaging manufacture
  • 3.3.4. Raw materials production
• 3.4. Global Endotoxin Testing Market Outlook, by Region, Value (US$ Bn), 2020-2033
  • 3.4.1. North America
  • 3.4.2. Europe
  • 3.4.3. Asia Pacific
  • 3.4.4. Latin America
  • 3.4.5. Middle East & Africa

4. North America Endotoxin Testing Market Outlook, 2020 - 2033

• 4.1. North America Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
  • 4.1.1. Gel Clot Endotoxin Test
  • 4.1.2. Chromogenic Endotoxin Test
  • 4.1.3. Turbidimetric Endotoxin Test
• 4.2. North America Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
  • 4.2.1. Endotoxin Detection Products
  • 4.2.2. LAL Test Reagents
  • 4.2.3. Mycoplasma Detection & Removal
  • 4.2.4. PCR Mycoplasma Detection Kit
  • 4.2.5. Mycoplasma Elimination Cocktail
  • 4.2.6. Mycoplasma Detection and Elimination Custom Services
  • 4.2.7. Accessories
  • 4.2.8. Instrumentation
  • 4.2.9. Endotoxin Removal Products
  • 4.2.10. Low Endotoxin Recovery (LER) Products
• 4.3. North America Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
  • 4.3.1. Medical device manufacturing
  • 4.3.2. Pharmaceutical manufacturing
  • 4.3.3. Packaging manufacture
  • 4.3.4. Raw materials production
• 4.4. North America Endotoxin Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
  • 4.4.1. U.S. Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 4.4.2. U.S. Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 4.4.3. U.S. Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 4.4.4. Canada Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 4.4.5. Canada Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 4.4.6. Canada Endotoxin Testing Market Outlook, by Application, 2020-2033
• 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Endotoxin Testing Market Outlook, 2020 - 2033

• 5.1. Europe Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
  • 5.1.1. Gel Clot Endotoxin Test
  • 5.1.2. Chromogenic Endotoxin Test
  • 5.1.3. Turbidimetric Endotoxin Test
• 5.2. Europe Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
  • 5.2.1. Endotoxin Detection Products
  • 5.2.2. LAL Test Reagents
  • 5.2.3. Mycoplasma Detection & Removal
  • 5.2.4. PCR Mycoplasma Detection Kit
  • 5.2.5. Mycoplasma Elimination Cocktail
  • 5.2.6. Mycoplasma Detection and Elimination Custom Services
  • 5.2.7. Accessories
  • 5.2.8. Instrumentation
  • 5.2.9. Endotoxin Removal Products
  • 5.2.10. Low Endotoxin Recovery (LER) Products
• 5.3. Europe Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
  • 5.3.1. Medical device manufacturing
  • 5.3.2. Pharmaceutical manufacturing
  • 5.3.3. Packaging manufacture
  • 5.3.4. Raw materials production
• 5.4. Europe Endotoxin Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
  • 5.4.1. Germany Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 5.4.2. Germany Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 5.4.3. Germany Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 5.4.4. Italy Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 5.4.5. Italy Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 5.4.6. Italy Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 5.4.7. France Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 5.4.8. France Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 5.4.9. France Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 5.4.10. U.K. Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 5.4.11. U.K. Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 5.4.12. U.K. Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 5.4.13. Spain Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 5.4.14. Spain Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 5.4.15. Spain Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 5.4.16. Russia Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 5.4.17. Russia Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 5.4.18. Russia Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 5.4.19. Rest of Europe Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 5.4.20. Rest of Europe Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 5.4.21. Rest of Europe Endotoxin Testing Market Outlook, by Application, 2020-2033
• 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Endotoxin Testing Market Outlook, 2020 - 2033

• 6.1. Asia Pacific Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
  • 6.1.1. Gel Clot Endotoxin Test
  • 6.1.2. Chromogenic Endotoxin Test
  • 6.1.3. Turbidimetric Endotoxin Test
• 6.2. Asia Pacific Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
  • 6.2.1. Endotoxin Detection Products
  • 6.2.2. LAL Test Reagents
  • 6.2.3. Mycoplasma Detection & Removal
  • 6.2.4. PCR Mycoplasma Detection Kit
  • 6.2.5. Mycoplasma Elimination Cocktail
  • 6.2.6. Mycoplasma Detection and Elimination Custom Services
  • 6.2.7. Accessories
  • 6.2.8. Instrumentation
  • 6.2.9. Endotoxin Removal Products
  • 6.2.10. Low Endotoxin Recovery (LER) Products
• 6.3. Asia Pacific Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
  • 6.3.1. Medical device manufacturing
  • 6.3.2. Pharmaceutical manufacturing
  • 6.3.3. Packaging manufacture
  • 6.3.4. Raw materials production
• 6.4. Asia Pacific Endotoxin Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
  • 6.4.1. China Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 6.4.2. China Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 6.4.3. China Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 6.4.4. Japan Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 6.4.5. Japan Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 6.4.6. Japan Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 6.4.7. South Korea Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 6.4.8. South Korea Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 6.4.9. South Korea Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 6.4.10. India Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 6.4.11. India Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 6.4.12. India Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 6.4.13. Southeast Asia Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 6.4.14. Southeast Asia Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 6.4.15. Southeast Asia Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 6.4.16. Rest of SAO Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 6.4.17. Rest of SAO Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 6.4.18. Rest of SAO Endotoxin Testing Market Outlook, by Application, 2020-2033
• 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Endotoxin Testing Market Outlook, 2020 - 2033

• 7.1. Latin America Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
  • 7.1.1. Gel Clot Endotoxin Test
  • 7.1.2. Chromogenic Endotoxin Test
  • 7.1.3. Turbidimetric Endotoxin Test
• 7.2. Latin America Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
  • 7.2.1. Endotoxin Detection Products
  • 7.2.2. LAL Test Reagents
  • 7.2.3. Mycoplasma Detection & Removal
  • 7.2.4. PCR Mycoplasma Detection Kit
  • 7.2.5. Mycoplasma Elimination Cocktail
  • 7.2.6. Mycoplasma Detection and Elimination Custom Services
  • 7.2.7. Accessories
  • 7.2.8. Instrumentation
  • 7.2.9. Endotoxin Removal Products
  • 7.2.10. Low Endotoxin Recovery (LER) Products
• 7.3. Latin America Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
  • 7.3.1. Medical device manufacturing
  • 7.3.2. Pharmaceutical manufacturing
  • 7.3.3. Packaging manufacture
  • 7.3.4. Raw materials production
• 7.4. Latin America Endotoxin Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
  • 7.4.1. Brazil Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 7.4.2. Brazil Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 7.4.3. Brazil Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 7.4.4. Mexico Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 7.4.5. Mexico Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 7.4.6. Mexico Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 7.4.7. Argentina Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 7.4.8. Argentina Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 7.4.9. Argentina Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 7.4.10. Rest of LATAM Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 7.4.11. Rest of LATAM Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 7.4.12. Rest of LATAM Endotoxin Testing Market Outlook, by Application, 2020-2033
• 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Endotoxin Testing Market Outlook, 2020 - 2033

• 8.1. Middle East & Africa Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
  • 8.1.1. Gel Clot Endotoxin Test
  • 8.1.2. Chromogenic Endotoxin Test
  • 8.1.3. Turbidimetric Endotoxin Test
• 8.2. Middle East & Africa Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
  • 8.2.1. Endotoxin Detection Products
  • 8.2.2. LAL Test Reagents
  • 8.2.3. Mycoplasma Detection & Removal
  • 8.2.4. PCR Mycoplasma Detection Kit
  • 8.2.5. Mycoplasma Elimination Cocktail
  • 8.2.6. Mycoplasma Detection and Elimination Custom Services
  • 8.2.7. Accessories
  • 8.2.8. Instrumentation
  • 8.2.9. Endotoxin Removal Products
  • 8.2.10. Low Endotoxin Recovery (LER) Products
• 8.3. Middle East & Africa Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
  • 8.3.1. Medical device manufacturing
  • 8.3.2. Pharmaceutical manufacturing
  • 8.3.3. Packaging manufacture
  • 8.3.4. Raw materials production
• 8.4. Middle East & Africa Endotoxin Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
  • 8.4.1. GCC Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 8.4.2. GCC Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 8.4.3. GCC Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 8.4.4. South Africa Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 8.4.5. South Africa Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 8.4.6. South Africa Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 8.4.7. Egypt Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 8.4.8. Egypt Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 8.4.9. Egypt Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 8.4.10. Nigeria Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 8.4.11. Nigeria Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 8.4.12. Nigeria Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 8.4.13. Rest of Middle East Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
  • 8.4.14. Rest of Middle East Endotoxin Testing Market Outlook, by the type, 2020-2033
  • 8.4.15. Rest of Middle East Endotoxin Testing Market Outlook, by Application, 2020-2033
• 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

• 9.1. Company Vs Segment Heatmap
• 9.2. Company Market Share Analysis, 2025
• 9.3. Competitive Dashboard
• 9.4. Company Profiles
  • 9.4.1. Thermo Fisher Scientific
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Product Portfolio
    • 9.4.1.3. Financial Overview
    • 9.4.1.4. Business Strategies and Developments
  • 9.4.2. Merck KGaA (MilliporeSigma)
  • 9.4.3. Charles River Laboratories
  • 9.4.4. Lonza Group
  • 9.4.5. bioMerieux SA
  • 9.4.6. Toxin Technology, Inc.
  • 9.4.7. Hycult Biotech
  • 9.4.8. Associates of Cape Cod, Inc.
  • 9.4.9. Sciex (Danaher)
  • 9.4.10. FUJIFILM Wako Chemicals USA Corporation

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Assumptions
• 10.3. Acronyms and Abbreviations